Catalyst
Slingshot members are tracking this event:
PDUFA Date of October 12th for AcelRx's (ACRX) ARX-04 (DSUVIA) New Drug Application in Moderate-to-Severe Pain
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ACRX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 12, 2017
Occurred Source:
http://ir.acelrx.com/news-releases/news-release-details/acelrx-pharmaceuticals-receives-complete-response-letter-fda
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pdufa Date, Fda, New Drug Application, Arx-04, Dsuvia, Moderate-to-severe Pain
